Research Tracker›Biomarker Atlas›Gulf War Illness›Brain-derived neurotrophic factor (BDNF)

Brain-derived neurotrophic factor (BDNF) in Gulf War Illness

In Gulf War Illness (GWI, Gulf War Syndrome), the direction of change for Brain-derived neurotrophic factor (BDNF), also described as Neurotrophin, is inconsistent across studies that used healthy Gulf War veteran controls as the reference group. Clinically, it has been associated with cognitive dysfunction. The finding is drawn from Gean et al. 2021; it describes group-level differences, not a threshold that classifies an individual.

↕ InconsistentNeurological

Summary

Direction in Gulf War Illness↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryNeurological
Also described asNeurotrophin
Compared againstHGV (healthy Gulf War veteran controls)
Associated symptomsCognitive dysfunction
Test typeBlood test (serum / plasma / whole blood)
SourceGean et al. 2021 — doi:10.1016/j.lfs.2021.119456
Condition atlasGulf War Illness Biomarker Atlas

Other conditions where Brain-derived neurotrophic factor (BDNF) is reported

See the cross-condition hub: Brain-derived neurotrophic factor (BDNF) across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Brain-derived neurotrophic factor (BDNF) (2 registered trials use a matching outcome measure).

Clinical trials using Brain-derived neurotrophic factor (BDNF) as an outcome

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Related Neurological markers in Gulf War Illness

Full list: Gulf War Illness Biomarker Atlas.

Frequently asked questions

Is Brain-derived neurotrophic factor (BDNF) high or low in Gulf War Illness?

Mixed. Some studies report higher and others lower Brain-derived neurotrophic factor (BDNF) in Gulf War Illness compared with healthy Gulf War veteran controls, so no single direction is established. Source: Gean et al. 2021.

What symptoms is Brain-derived neurotrophic factor (BDNF) associated with in Gulf War Illness?

The cited literature associates this marker with Cognitive dysfunction. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Brain-derived neurotrophic factor (BDNF)?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Brain-derived neurotrophic factor (BDNF) result diagnostic of Gulf War Illness?

No. No single biomarker is diagnostic of Gulf War Illness. Brain-derived neurotrophic factor (BDNF) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Brain-derived neurotrophic factor (BDNF) specific to Gulf War Illness?

No. The same marker is also reported in Major Depressive Disorder in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Brain-derived neurotrophic factor (BDNF) in Gulf War Illness: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/gulf-war-illness/brain-derived-neurotrophic-factor-bdnf.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from gulf-war-illness.json · Browse: Gulf War Illness atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.